↓ Skip to main content

Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma

Overview of attention for article published in Journal of Translational Medicine, January 2007
Altmetric Badge

Mentioned by

wikipedia
4 Wikipedia pages

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
Published in
Journal of Translational Medicine, January 2007
DOI 10.1186/1479-5876-5-2
Pubmed ID
Authors

Elsa F Velazquez, Molly Yancovitz, Anna Pavlick, Russell Berman, Richard Shapiro, Dusan Bogunovic, David O'Neill, Yi-Lo Yu, Joanna Spira, Paul J Christos, Xi Kathy Zhou, Madhu Mazumdar, David M Nanus, Leonard Liebes, Nina Bhardwaj, David Polsky, Iman Osman

Abstract

Overexpression of Neutral Endopeptidase (NEP) has been reported in metastatic carcinomas, implicating NEP in tumor progression and suggesting a role for NEP inhibitors in its treatment. We investigated the role of NEP expression in the clinical progression of cutaneous melanoma.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 4%
Unknown 26 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 30%
Researcher 4 15%
Student > Ph. D. Student 3 11%
Professor 2 7%
Student > Postgraduate 2 7%
Other 6 22%
Unknown 2 7%
Readers by discipline Count As %
Medicine and Dentistry 11 41%
Agricultural and Biological Sciences 6 22%
Biochemistry, Genetics and Molecular Biology 4 15%
Mathematics 2 7%
Engineering 1 4%
Other 0 0%
Unknown 3 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2022.
All research outputs
#7,539,423
of 23,001,641 outputs
Outputs from Journal of Translational Medicine
#1,250
of 4,020 outputs
Outputs of similar age
#42,627
of 157,991 outputs
Outputs of similar age from Journal of Translational Medicine
#6
of 12 outputs
Altmetric has tracked 23,001,641 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,020 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 157,991 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.